International Journal of Molecular Sciences Article The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats Vesna Ja´cevi´c 1,2,3 ID , Viktorija Dragojevi´c-Simi´c 2,4, Željka Tatomirovi´c 2,5, Silva Dobri´c 2,6 ID , Dubravko Bokonji´c 2, Aleksandra Kovaˇcevi´c 2,4, Eugenie Nepovimova 3, Martin Vališ 7 and Kamil Kuˇca 3,* ID 1 Department of Experimental Toxicology and Pharmacology, National Poison Control Centre, Military Medical Academy, 11 Crnotravska St, 11000 Belgrade, Serbia;
[email protected] 2 Medical Faculty of the Military Medical Academy, University of Defense in Belgrade, 1 Pavla Juriši´ca-Šturma St, 11000 Belgrade, Serbia;
[email protected] (V.D.-S.);
[email protected] (Ž.T.);
[email protected] (S.D.);
[email protected] (D.B.);
[email protected] (A.K.) 3 Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanského 62, 50003 Hradec Králové, Czech Republic;
[email protected] 4 Centre for Clinical Pharmacology, Military Medical Academy, 11 Crnotravska St, 11000 Belgrade, Serbia 5 Institute for Pathology, Military Medical Academy, 11 Crnotravska St, 11000 Belgrade, Serbia 6 Institute for Scientific Information, University of Defense in Belgrade, 1 Pavla Juriši´ca-ŠturmaSt, 11000 Belgrade, Serbia 7 Department of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Kralove and University Hospital, Simkova 870, 50003 Hradec Králové, Czech Republic;
[email protected] * Correspondence:
[email protected]; Tel.: +420-603-289-166 Received: 30 June 2018; Accepted: 7 August 2018; Published: 12 August 2018 Abstract: Amifostine is well known cytoprotector which is efficient when administered before a wide range of antineoplastic agents.